TeamHealth has shut down a private merger offer from AmSurg Corp. TeamHealth is a hospital staffing company while AmSurg aids in running clinics and surgery centers, Bloomberg said. This was announced shortly after the latter has announced that it is engaging with TeamHealth on Tuesday, Reuters said. The offer was at USD5.3 billion at USD71.47 per share, of which TeamHealth is quick to retort that the offer is undervalued. It was noted that the offer was at a 36 percent premium of TeamHealth’s closing price on Monday.
Under the terms of the merger offer, the new company will assume the TeamHealth name and will continue to operate from its headquarters in Knoxville, Tennessee, Street Insider reports. Moreover, the Board of Directors will be filled with representatives from both companies, with AmSurg President and Chief Executive Officer Christopher Holden acting as the new CEO.
In a letter addressed to the members of TeamHealth’s Board, Holden said, “We are disappointed to learn that you chose not to engage with us based on what appears to be a very cursory analysis of our specific proposal and key deal terms.”
If the merger happened, the new company will have about 1,200 health-care facilities and 20,000 clinical workers in its stead, Amsurg said.


Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 



